Patent · US Active

Amorphous solid dispersions

US7713548B2 · kind B2 · utility

0Cited by

5References

33Claims

0Family size

Assignee

Sanofi-Aventis U.S. LLC · US

Inventors

Irwin C. Jacobs · Eureka, US
John D. Higgins, III · Whitemarsh, US
Micael Guillot · Lansdale, US
Nancy M. Franson · Collegeville, US
William L. Rocco · Reading, US
Khawla Abu-Izza · Highland Mills, US

Key dates

Filing date	Feb 12, 2008
Grant date	May 11, 2010
Priority date	—
Expiry date	Jun 15, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are amorphous solid dispersion formulations comprising 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.